The upregulation of TLR4 and HMGB1 is synergistic and results in the increase of HLA-G, a non-classical HLA class I antigen that participates in glioma immune evasion (Gupta et al., 2013). This evidence concerns the gene HMGB1 and central nervous system cancer.